| Symbol | IMVT |
|---|---|
| Name | IMMUNOVANT, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 320 WEST 37TH STREET,6TH FLOOR, NEW YORK, New York, 10018, United States |
| Telephone | +1 917 580-3099 |
| Fax | — |
| — | |
| Website | https://www.immunovant.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001764013 |
| Description | Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The companys product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). Additional info from NASDAQ: |
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
Read moreDirector Pande Atul 🟡 adjusted position in 1.5K shares (1 derivative) of Immunovant, Inc. (IMVT) at $39.80 Transaction Date: Jul 24, 2026 | Filing ID: 000007
Read moreGirao Tiago 🔴 sold 6.8K shares of Immunovant, Inc. (IMVT) at $38.69 Transaction Date: Jul 23, 2026 | Filing ID: 000004
Read moreStout Jay S 🔴 sold 2.9K shares of Immunovant, Inc. (IMVT) at $38.69 Transaction Date: Jul 23, 2026 | Filing ID: 000010
Read moreImmunovant to Report Financial Results forthe First Quarter Ended June 30, 2026, and Provide BusinessUpdate on Thursday, August 6, 2026
Read moreImmunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Read moreNew Form DEFA14A - Immunovant, Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001764013-26-000093 <b>Size:</b> 1 MB
Read moreDirector Venker Eric 🟡 adjusted position in 89.7K shares (1 derivative) of Immunovant, Inc. (IMVT) at $38.48 ($6.1M) Transaction Date: Jul 01, 2026 | Filing ID: 000077
Read moreGloria Melanie 🔴 sold 17.7K shares of Immunovant, Inc. (IMVT) at $38.95 Transaction Date: Jun 26, 2026 | Filing ID: 000075
Read moreStout Jay S 🔴 sold 40.0K shares of Immunovant, Inc. (IMVT) at $38.94 ($1.5M) Transaction Date: Jun 26, 2026 | Filing ID: 000074
Read more